GAMMA/DELTA T CELLS IN TOLERANCE AND TUMOR IMMUNITY
GAMMA/DELTA T CELLS IN TOLERANCE AND TUMOR IMMUNITY
批准号:
2414453
负责人:
JUDITH A KAPP
金额:
$23.68万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1996
资助国家:
美国
项目状态:
已结题
起止时间:
1996-05-01 至 1999-04-30
中文摘要
我们计划验证γ-δ T细胞在免疫系统中起重要作用的假设。
在对外源性和内源性抗原的耐受性中的作用。这个想法是基于
我们的实验确定了CD 8 + T细胞如何下调免疫
应答我们已经证明,外源性抗原,如卵清蛋白(OVA),
与完全弗氏佐剂(CFA)混合引发OVA特异性、MHC类
I限制性,CD 8 + CTL。将这些CTL转移到幼稚的、同基因的
受体抑制OVA特异性反应,表明CTL可以
解释了CD 8 + T细胞的一些抑制活性。测试
CTL是否参与典型的抑制模型,口服
研究了对OVA的耐受性。我们发现口服卵蛋白确实
而不是引发CTL,而是抑制CTL的引发。此外,CD 8 +
来自耐受小鼠的脾T细胞将耐受性转移至未处理小鼠
这表明并非所有的抑制因子都是CTL。此外,预处理
具有抗γ-δ TcR抗体的小鼠通过以下方式阻止耐受诱导:
OVA和逆转胰岛素自身耐受。间接证据表明
抗γ-δ抗体通过以下方式干扰耐受性诱导
耗尽γ-δ T细胞此外,口服OVA未能
在γ-δ基因敲除小鼠中诱导耐受性,
支持γ-δ T细胞在免疫系统中发挥重要作用的解释。
在耐受诱导中的作用。
该项目的目标是确定γ-δ T细胞的作用
在使用OVA作为外源性或内源性抗原的耐受性中,
特别强调OVA作为肿瘤抗原。我们将测试
通过口服给予OVA诱导的CD 8+抑制性T细胞是γ-
δ T细胞或γ-δ T细胞是否调节
CD 8+抑制性T细胞。我们将确定γ-δ T细胞是否
OVA特异性的,并产生T细胞克隆或杂交瘤,以研究其
受体。γ-δ T细胞在自身耐受性中的作用也将在
使用表达OVA基因的转基因(Tg)小鼠进行研究。我们将
确定这些小鼠是否耐受CFA中的OVA,以及抗-
γ-δ抗体逆转耐受性。将给予Tg小鼠口服OVA,
确定γ-δ T细胞和/或CD 8+抑制性T细胞是否
宽容γ-δ T细胞可能参与
将使用EL 4细胞测试肿瘤被排斥的失败
表达OVA基因作为肿瘤模型。宽容的影响或
将评估对OVA的免疫对肿瘤排斥的影响,
抗γ-δ抗体对肿瘤排斥反应的影响将在正常人中进行评估。
和OVA Tg小鼠。用共刺激因子转染的肿瘤的能力,
克服耐受性和诱导排斥反应将在正常和Tg中进行比较
小鼠
英文摘要
We plan to test the hypothesis that gamma-delta T cells play an important
role in tolerance to exogenous and endogenous antigens. This idea is based
on our experiments determining how CD8+ T cells down regulate immune
responses. We have shown that exogenous antigens, such as ovalbumin (OVA)
mixed with complete Freund's adjuvant (CFA) primes OVA-specific, MHC class
I restricted, CD8+ CTL. Transfer of these CTL to naive, syngeneic
recipients inhibited OVA-specific responses suggesting that CTL could
account for some of the suppressor activities of CD8+ T cells. To test
whether CTL were involved in a typical model involving suppression, oral
tolerance to OVA was studied. We found that oral administration of OVA did
not prime CTL but rather inhibited the priming of CTL. in addition, CD8+
splenic T cells from tolerant mice transferred tolerance to naive mice
suggesting that not all suppressors are CTL. Moreover, pretreatment of
mice with anti-gamma-delta TcR antibody prevented tolerance induction by
OVA and reversed self tolerance to insulin. Indirect evidence suggests
that anti-gamma-delta antibody interferes with tolerance induction by
depleting gamma-delta T cells. Also, oral administration of OVA failed to
induce tolerance in gamma-delta knock out mice providing additional
support for the interpretation that gamma-delta T cells play an essential
role in tolerance induction.
The goal of this project is to determine the role of gamma-delta T cells
in tolerance using OVA as an extrinsic or an intrinsic antigen with
particular emphasis on OVA as a tumor antigen. We will test whether the
CD8+ suppressor T cells induced by oral administration of OVA are gamma-
delta T cells or whether gamma-delta T cells regulate the activation of
CD8+ suppressor T cells. We will determine whether gamma-delta T cells are
OVA-specific and produce T cell clones or hybridomas to study their
receptors. The role of gamma-delta T cells in self-tolerance also will be
studied using transgenic (Tg) mice expressing the OVA gene. We will
determine whether these mice are tolerant to OVA in CFA and whether anti-
gamma-delta antibody reverses tolerance. Tg mice will be given oral OVA to
determine whether gamma-delta T cells and/or CD8+ suppressor T cells are
tolerant. The possibility that gamma-delta T cells could be involved in
the failure of tumors to be rejected will be tested using EL4 cells
expressing the OVA gene as a tumor model. The effect of tolerance or
immunity to OVA on tumor rejection will be evaluated and the effect of
anti-gamma-delta antibody on tumor rejection will be assessed in normal
and OVA Tg mice. The ability of tumors transfected with co-stimulators to
overcome tolerance and induce rejection will be compared in normal and Tg
mice.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Retinal Cell Transplantation Tolerance and Rejection
-
批准号:7068479
-
项目类别:
-
资助金额:$31.86万
-
财政年份:2004
-
负责人:JUDITH A KAPP
-
依托单位:
Retinal Cell Transplantation Tolerance and Rejection
-
批准号:6912734
-
项目类别:
-
资助金额:$32.63万
-
财政年份:2004
-
负责人:JUDITH A KAPP
-
依托单位:
Retinal Cell Transplantation Tolerance and Rejection
-
批准号:6789520
-
项目类别:
-
资助金额:$32.63万
-
财政年份:2004
-
负责人:JUDITH A KAPP
-
依托单位:
Retinal Cell Transplantation Tolerance and Rejection
-
批准号:7235606
-
项目类别:
-
资助金额:$31.68万
-
财政年份:2004
-
负责人:JUDITH A KAPP
-
依托单位:
Regulation of Ocular Tolerance by Gamma/delta T Cells
-
批准号:6635735
-
项目类别:
-
资助金额:$30.4万
-
财政年份:2001
-
负责人:JUDITH A KAPP
-
依托单位:
Regulation of Ocular Tolerance by Gamma/delta T Cells
-
批准号:6318736
-
项目类别:
-
资助金额:$30.45万
-
财政年份:2001
-
负责人:JUDITH A KAPP
-
依托单位:
Regulation of Ocular Tolerance by Gamma/delta T Cells
-
批准号:6518724
-
项目类别:
-
资助金额:$30.4万
-
财政年份:2001
-
负责人:JUDITH A KAPP
-
依托单位:
Regulation of Ocular Tolerance by Gamma/delta T Cells
-
批准号:6896318
-
项目类别:
-
资助金额:$30.4万
-
财政年份:2001
-
负责人:JUDITH A KAPP
-
依托单位:
GAMMA/DELTA T CELLS IN TOLERANCE AND TUMOR IMMUNITY
-
批准号:6376248
-
项目类别:
-
资助金额:$24.17万
-
财政年份:1996
-
负责人:JUDITH A KAPP
-
依托单位:
GAMMA/DELTA T CELLS IN TOLERANCE AND TUMOR IMMUNITY
-
批准号:2114274
-
项目类别:
-
资助金额:$23.08万
-
财政年份:1996
-
负责人:JUDITH A KAPP
-
依托单位:
GAMMA/DELTA T CELLS IN TOLERANCE AND TUMOR IMMUNITY
-
批准号:2700672
-
项目类别:
-
资助金额:$24.31万
-
财政年份:1996
-
负责人:JUDITH A KAPP
-
依托单位:
GAMMA/DELTA T CELLS IN TOLERANCE AND TUMOR IMMUNITY
-
批准号:6173216
-
项目类别:
-
资助金额:$23.61万
-
财政年份:1996
-
负责人:JUDITH A KAPP
-
依托单位:
GAMMA/DELTA T CELLS IN TOLERANCE AND TUMOR IMMUNITY
-
批准号:2848368
-
项目类别:
-
资助金额:$23.04万
-
财政年份:1996
-
负责人:JUDITH A KAPP
-
依托单位:
ROLE OF MHC GENES IN IMMUNOREGULATION
-
批准号:2060027
-
项目类别:
-
资助金额:$12.44万
-
财政年份:1993
-
负责人:JUDITH A KAPP
-
依托单位:
ROLE OF MHC GENES IN IMMUNOREGULATION
-
批准号:3125599
-
项目类别:
-
资助金额:$8.3万
-
财政年份:1992
-
负责人:JUDITH A KAPP
-
依托单位:
ROLE OF MHC GENES IN IMMUNOREGULATION
-
批准号:3125600
-
项目类别:
-
资助金额:$17.71万
-
财政年份:1992
-
负责人:JUDITH A KAPP
-
依托单位:
STRUCTURE AND EXPRESSION OF SUPPRESSOR T CELL PRODUCTS
-
批准号:3128366
-
项目类别:
-
资助金额:$29.35万
-
财政年份:1982
-
负责人:JUDITH A KAPP
-
依托单位:
STRUCTURE AND EXPRESSION OF SUPPRESSOR T CELL PRODUCTS
-
批准号:3128367
-
项目类别:
-
资助金额:$28.14万
-
财政年份:1982
-
负责人:JUDITH A KAPP
-
依托单位:
ROLE OF MHC GENES IN IMMUNREGULATION
-
批准号:3125591
-
项目类别:
-
资助金额:$18.04万
-
财政年份:1977
-
负责人:JUDITH A KAPP
-
依托单位:
MODE OF ACTION OF H-LINKED IMMUNE RESPONSE (IR) GENES
-
批准号:3125595
-
项目类别:
-
资助金额:$19.9万
-
财政年份:1977
-
负责人:JUDITH A KAPP
-
依托单位:
海外基金